Kenvue

KVUE · NYSE

$19.28+$0.41 (+2.17%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $18.87

Latest news

NewsOct 16, 10:52 AM ET
'Kimberly-Clark Readies Bond Sale Ahead of Tylenol Maker Purchase' - Bloomberg
NewsOct 15, 11:52 AM ETLekha Gupta
Huggies Maker Kimberly-Clark Sticks To 2026 Profit Outlook
Press releaseOct 13, 7:00 AM ETPRNewswire
Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers
Press releaseOct 1, 7:00 AM ETPRNewswire
Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team
Press releaseOct 1, 6:45 AM ETBusiness Wire
LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion
Press releaseSep 30, 6:45 AM ETBusiness Wire
Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
Press releaseSep 28, 4:05 PM ETPRNewswire
Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes
NewsSep 16, 9:24 AM ETVandana Singh
Kimberly-Clark May Sell Assets to Save Its $40 Billion Kenvue Deal: Report
Press releaseSep 10, 6:45 AM ETBusiness Wire
Kenvue Declares Quarterly Cash Dividend
NewsSep 9, 9:51 AM ET
Reported September 8, 2026: 'Tylenol Use In Pregnancy May Be Linked With Uterus, Ovary Changes In Daughters' - Reuters News
Press releaseAug 13, 9:25 AM ETPRNewswire
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel
NewsAug 10, 11:01 PM ETRadhika Anilkumar Nadig
Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)
NewsAug 7, 8:36 AM ETNamrata Sen
Trump Administration Reportedly Weighs Executive Order on Autism and Vaccines Days After RFK Jr. Hinted At 'Certain Interventions'
Press releaseAug 6, 6:45 AM ETBusiness Wire
Kenvue Reports Second Quarter 2026 Results
Press releaseJul 29, 6:45 AM ETBusiness Wire
Kenvue Increases Quarterly Cash Dividend
NewsJul 28, 10:10 AM ETVandana Singh
Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest
NewsJul 24, 10:49 AM ET
FDA Approves First Nonprescription Fixed-Dose Combination Of Acetaminophen, Naproxen Sodium For 12-Hour Pain Relief
Press releaseJul 23, 6:45 AM ETBusiness Wire
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
NewsMay 7, 6:35 AM ET
Kenvue Q1 Adj. EPS $0.32 Beats $0.26 Estimate, Sales $3.909B Beat $3.842B Estimate
Press releaseMay 7, 6:30 AM ETBusiness Wire
Kenvue Reports First Quarter 2026 Results
Press releaseApr 29, 6:45 AM ETBusiness Wire
Kenvue Declares Quarterly Cash Dividend
NewsApr 24, 2:19 PM ETLekha Gupta
Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%
Press releaseApr 23, 4:32 PM ETBusiness Wire
Kenvue to Announce First Quarter 2026 Results on May 7, 2026
Press releaseApr 15, 8:55 AM ETPRNewswire
Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership
NewsMar 10, 1:59 PM ETVandana Singh
FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder
NewsMar 10, 12:42 PM ETTim Melvin
8 Stocks to Buy as Merger-Mania Takes Over
NewsFeb 17, 4:48 PM ET
Earnings Summary: Kenvue Q4
NewsFeb 17, 4:46 PM ET
Kenvue Q4 Adj. EPS $0.27 Beats $0.22 Estimate, Sales $3.780B Beat $3.681B Estimate
Press releaseFeb 17, 4:45 PM ETBusiness Wire
Kenvue Reports Fourth Quarter and Full Year 2025 Results
NewsFeb 16, 9:02 AM ET
Kenvue Earnings Preview
NewsFeb 12, 9:22 AM ETVandana Singh
What's Going On With Neutrogena Maker Kenvue Stock On Thursday?
Press releaseFeb 4, 6:45 AM ETBusiness Wire
Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026
Press releaseJan 29, 9:27 AM ETPRNewswire
Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue
Press releaseJan 28, 6:45 AM ETBusiness Wire
Kenvue Declares Quarterly Cash Dividend
NewsJan 19, 5:00 PM ET
A Look Into Kenvue Inc's Price Over Earnings
NewsDec 8, 9:00 AM ET
P/E Ratio Insights for Kenvue
NewsNov 20, 8:11 AM ETAvi Kapoor
Jim Cramer: This Communication Services Stock Is 'Too Speculative'
NewsNov 6, 3:29 PM ET
'Attorney General Ken Paxton Fights To Stop The Manufacturer Of Tylenol From Fraudulently Paying Dividends To Avoid Facing Justice' - Texas AG
NewsNov 6, 12:23 PM ET
Texas Attorney General Ken Paxton Files Motion To Prevent Kenvue From Paying Out November Dividend
NewsSep 27, 1:15 PM ET
P/E Ratio Insights for Kenvue

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

'Kimberly-Clark Readies Bond Sale Ahead of Tylenol Maker Purchase' - Bloomberg

Huggies Maker Kimberly-Clark Sticks To 2026 Profit Outlook

Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team

LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion

Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair

Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes

Kimberly-Clark May Sell Assets to Save Its $40 Billion Kenvue Deal: Report

Kenvue Declares Quarterly Cash Dividend

Reported September 8, 2026: 'Tylenol Use In Pregnancy May Be Linked With Uterus, Ovary Changes In Daughters' - Reuters News

Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel

Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)

Trump Administration Reportedly Weighs Executive Order on Autism and Vaccines Days After RFK Jr. Hinted At 'Certain Interventions'

Kenvue Reports Second Quarter 2026 Results

Kenvue Increases Quarterly Cash Dividend

Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest

FDA Approves First Nonprescription Fixed-Dose Combination Of Acetaminophen, Naproxen Sodium For 12-Hour Pain Relief

Kenvue to Announce Second Quarter 2026 Results on August 6, 2026

Kenvue Q1 Adj. EPS $0.32 Beats $0.26 Estimate, Sales $3.909B Beat $3.842B Estimate

Kenvue Reports First Quarter 2026 Results

Kenvue Declares Quarterly Cash Dividend

Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64%

Kenvue to Announce First Quarter 2026 Results on May 7, 2026

Kimberly-Clark Announces Post-Closing Organizational Structure and Identifies Key Leadership

FDA Expands Use Of Generic Drug To Treat Autism-Linked Genetic Disorder

8 Stocks to Buy as Merger-Mania Takes Over

Earnings Summary: Kenvue Q4

Kenvue Q4 Adj. EPS $0.27 Beats $0.22 Estimate, Sales $3.780B Beat $3.681B Estimate

Kenvue Reports Fourth Quarter and Full Year 2025 Results

Kenvue Earnings Preview

What's Going On With Neutrogena Maker Kenvue Stock On Thursday?

Kenvue to Announce Fourth Quarter and Full Year 2025 Results on February 17, 2026

Kimberly-Clark and Kenvue Shareholders Overwhelmingly Approve Kimberly-Clark's Acquisition of Kenvue

Kenvue Declares Quarterly Cash Dividend

A Look Into Kenvue Inc's Price Over Earnings

P/E Ratio Insights for Kenvue

Jim Cramer: This Communication Services Stock Is 'Too Speculative'

'Attor­ney Gen­er­al Ken Pax­ton Fights To Stop The Man­u­fac­tur­er Of Tylenol From Fraud­u­lent­ly Pay­ing Div­i­dends To Avoid Fac­ing Justice' - Texas AG

Texas Attorney General Ken Pax­ton Files Motion To Prevent Kenvue From Paying Out November Dividend

P/E Ratio Insights for Kenvue

'Attorney General Ken Paxton Fights To Stop The Manufacturer Of Tylenol From Fraudulently Paying Dividends To Avoid Facing Justice' - Texas AG

Texas Attorney General Ken Paxton Files Motion To Prevent Kenvue From Paying Out November Dividend